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ABSTRACT 
The aim of the thesis was to evaluate magnetic resonance imaging (MRI) as an outcome in 
the evaluation of treatment in mid-portion Achilles tendinosis. Conventional MRI sequences, 
dynamic contrast enhanced MRI and measurement of transversal relaxation time, using an 
ultrashort time to echo sequence, has been evaluated. 
In study I intratendinous signal and tendon volume was evaluated in five different MR-
sequences, using a computerized data program, in patients with unilateral chronic Achilles 
tendinopathy. Increased intratendinous signal on MRI correlated to increased severity of pain 
and functional impairment. A significant difference of intratendinous signal between the 
symptomatic and the contralateral asymptomatic tendons was found in all sequences except 
in T2-weighted images. Contrast enhanced T1-WI did not contribute to an improved 
correlation to clinical score compared to other sequences. The symptomatic Achilles tendons 
had a higher mean volume compared to the contralateral asymptomatic tendons but the 
volume did not correlate to clinical scores.  
In study II symptoms and MRI findings were evaluated four to five years after eccentric 
calf-muscle treatment in patients with chronic Achilles tendinosis. Semi-quantitative 
evaluation showed decreased intratendinous signal in the symptomatic treated tendons after 
4.2 years both compared to inclusion and after 3 months of eccentric calf-muscle training. 
The clinical scores were significantly improved both compared to inclusion and at 3 
months. The decrease in tendon volume was not statistically significant.  
In study III dynamic contrast-enhancement in tendon and in fat ventrally of the tendon in 
patients with Achilles tendinosis was evaluated before and after three months of eccentric 
calf-muscle training. In the fat ventrally of the tendon there was a significantly increased 
contrast enhancement in the symptomatic side compared to the contralateral non-
symptomatic side before treatment that disappeared after three months of training. However 
there was no significant change of enhancement before compared to after training and there 
was no correlation of dynamic contrast enhancement to symptoms. 
In study IV the short-term repeatability of the UTE sequence was evaluated and T2* in 
patients with chronic Achilles tendinopathy was compared to healthy controls. There was a 
significant difference in mean T2* between the 20 symptomatic tendons and the 20 control 
tendons. In the 13 patients with unilateral symptoms a significant difference in T2* was 
found between the symptomatic tendons and their contralateral asymptomatic tendon. The 
short-term repeatability of the UTE-sequence showed a CV of 35% and intra-class correlation 
with an average consistency of 0.98. The least significant change was 98%. There was no 
significant correlation between VISA-A and T2*. 
Conclusions: Increased intratendinous signal on MRI correlate to clinical scoring in patients 
with chronic mid-portion Achilles tendinopathy but the arbitrary scaling of intratendinous 
signal makes the computerized method unreliable as an outcome measure.  
The significantly better clinical outcome and decreased intratendinous signal on MRI after 
four to five years compared to directly after the eccentric training program indicates that the 
  
long-term prognosis in chronic Achilles tendinosis is good. A remaining high volume may 
be a remnant of a previous disorder.  
We could not show any additional value of dynamic contrast enhanced MRI compared to 
MRI without contrast media.  
T2* relaxation obtained with a UTE sequence is able to differentiate between chronic 
Achilles tendinosis and healthy controls but it was not associated with the clinical index. 
There was a low reproducibility of the method limiting future evaluation of treatment effect 
to the group level.  
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1 INTRODUCTION 
 
1.1 BACKGROUND 
 
Chronic Achilles tendinopathy is common and may especially appear in athletes but also in 
non- athletes (Kvist 1991, Åström 1996, Rolf 1997). In the management of chronic Achilles 
tendinopathy a variety of treatments have been evaluated (Magnussen 2009, Roche 2013, 
Zweiers 2014). There is lack of evidence of the efficacy of the treatments because of few 
randomized controlled studies, heterogenic treatment groups and interventions and a wide 
range of outcome measurements used with little consistency between different studies. The 
most common outcome measurements are questionnaires and pain scores which are not fully 
objective since the treatment most often cannot be blinded.  
The goal of this thesis is to evaluate magnetic resonance imaging (MRI) as an outcome in the 
evaluation of treatment of mid-portion Achilles tendinopathy. MRI of Achilles tendinopathy 
typically demonstrates a thickening of the tendon and a focal or diffusely raised 
intratendinous signal (Quinn 1987, Bergquist 1990, Åström 1996). The signal alterations 
have been shown to correlate to pathological changes in histological samples (Åström 1996). 
However there are varying degrees of overlap between clinically symptomatic and non-
symptomatic tendons at MR imaging. (Soila 1999, Haims 2000) During the last decade an 
ultra-short time to echo pulse sequence (UTE-sequence) has become more commonly used in 
tendons (Robsson 2004, Filho 2009, Juras 2012, Grosse 2013). With UTE-sequences early 
tendon changes can be detected and quantified by different quantitative parameters.  
 
 
1.2 ANATOMY AND STRUCTURE OF THE ACHILLES TENDON 
The Achilles tendon is the strongest and thickest tendon of the body (Soma 1994). It is a 
traction tendon, formed by the junction of the gastrocnemius and soleus muscles and inserts 
by an enthesis into the calcaneal bone (Drake 2005). As the Achilles tendon descends the 
tendon fibers rotate laterally approximately 90 degrees producing a concentrated pressure 
where the tendon bundles meet (Jozsa 1997). The tendon may be exposed to forces as high 
as 3.9 times of the bodyweight when walking and 7.7 times when running (Giddings 2000). 
There is great variation in mean thickness of normal Achilles tendons between different 
studies ranging from 4.2 to7.1 mm (Koivunen-Niemelä 1995). A positive correlation of age, 
height and body weight to tendon thickness has been found in the adult population. 
 
The Achilles tendon is surrounded by the paratenon, a multi-layered non-synovial tissue that 
facilitates movement (Jozsa 1997). The tendon receives its blood supply from the paratenon 
and from the muscle-tendon and bone-tendon junctions (Carr 1989, Josza 1997). Fig 1.  
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Fig 1. Illustration of the blood supply of the Achilles tendon from (A) the bone-tendon 
junction (B) the muscle-tendon junction and (C) the paratenon. From the thesis by Shalabi, 
Magnetic resonance imaging in chronic Achilles tendinopathy 2004, with permission. 
 
 
 
 
 
 
Under the paratenon the tendon is surrounded by the epitenon which is contiguous with the 
endontenon that binds the collagen fiber together into primary, secondary and tertiary fiber 
bundles. A collagen fiber consists of varying number of fibrils that are made from collagen 
molecules arranged in a specific pattern (Maffulli 2005). Fig 2. The collagen molecules 
consist of three amino-acid chains, alpha-chains, and are in tendons primarily of type 1 
collagen. In a resting state the collagen fibers show a wavy configuration that disappears if 
the tendon is stretched slightly (Rowe 1985). The collagen fibrils in traction tendons are 
orientated in the traction direction. The tendon react under increased mechanical strain with 
hypertrophy of the collagen fibrils (Michna 1984). 
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Fig 2. Schematic drawing of the tendon structure. From the thesis by Shalabi, Magnetic 
resonance imaging in chronic Achilles tendinopathy 2004, with permission. 
 
 
 
80-90% of the dry weight of tendon is collagen and of the total weight of freshly dissected 
tendons 60% is water (Vogel 1999). The collagen fibrils are surrounded by ground substance 
containing proteoglukans and glycosaminoglukans that have a high water binding capacity 
(Jozsa 1997). The water in tissues can be divided into different compartments depending on 
its binding to other molecules (Peto 1990, Robsson 2003, Fullerton 2007). A suggested model 
for tendon is a three compartment model. One compartment is the interstitial water where the 
water molecules are tightly bound by two hydrogen bonds forming water bridges inside the 
collagen molecules. The second compartment is water molecules covering the collagen 
molecules like a water sheath. These water molecules are less tightly bound to the collagen 
molecules by positive and negative charges. The last fraction is located between the fibrils in 
the ground substance.  
 
1.3 ACHILLES TENDINOSIS 
1.3.1 Ethiology and pathology  
Excessive physical activity is thought to be a major triggering factor of Achilles tendinosis 
(Kvist 1991). Several other intrinsic and extrinsic risk factors have been reported such as age, 
gender, genetic vulnerability, systemic and metabolic diseases, drugs and training errors but 
the exact etiological pathway is still unclear even though most agree that it is usually a result 
from a combination of different pathways (Järvinen 1992, Åström 1995, van der Linden 
2002, Maffulli 2003, Riley 2004, Gaida 2009, Ribbans 2013, Magnan 2014). 
Macroscopically tendinosis is seen as poorly demarcated regions with loss of tendon structure 
(Åström 1996, Paavola 2002). Typical histopathological findings are irregular fiber structure 
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with loss of parallel arrangement and decreased collagen stainability, increased non-collagen 
extracellular matrix, regional variations in cellularity, rounded nuclei of cells and areas of 
hyper vascularity (Åström 1996, Movin1997). Fig 3. Several subcategories such as mucoid, 
hypoxic, fibrinoid, lipomatous and calcific have also been identified. These types overlap and 
are probably a result of different etiologies (Maffulli 2003). Higher age correlate to more 
abnormal histopathological findings (Åström 1996). 
 
 
 
A                                                                      B 
Figure 3. Histopathological images from (A) a normal tendon and from (B) a tendon with 
tendinosis. 
 
 
It has been hypothesized that a reduced vascularity in the mid-portion of the Achilles tendon 
would be of significance in the etiology of Achilles tendinosis (Carr 1989, Pufe 2005). This 
area is also where most ruptures occur (Jozsa 1997). One hypothesis has been that a force 
reapplied before recovery from injury would lead to tendinosis promoted by delayed 
healing in the hypovascular tendon tissue (Leadbetter 1992). This hypo-vascular zone was 
described in cadavers originally 1958 by Lagergren and Lindholm and later by others (Carr 
1989, Stein 2000). But other studies in vivo with laser Doppler technique have shown low 
vascularity rather in the distal part of the tendon and not in the middle part (Åström 1994). 
Biopsies and laser or ultrasound Doppler flow examinations in patients with Achilles 
tendinosis have shown areas of increased blood vessels and blood flow in the degenerative 
tendons (Åström 1994, Movin 1997, Öhberg 2001, Alfredsson 2003, Knoblosh 2006). Neo-
vessels may be part of a reparative process at least in an acute phase. During remodeling of 
tendon auto-grafts angiogenesis contributes to repair of the graft but may also cause 
reduced mechanical strength (Petersen 2003, Pufe 2005). Angiogenesis is controlled by 
several stimulatory and inhibitory proteins necessary for the development and maintenance 
of tissues (Neufeld 1999). One of the most important angiogenic factors is the VEGF. 
Higher concentrations of VEGF have been detected in degenerative tendon tissue compared 
to controls (Pufe 2001). 
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Biopsies have shown nerve structures in close relation to the neo-vessels in Achilles 
tendinosis (Alfredson 2003). Neuropeptides such as substance P and calcitonin gene-related 
peptide have been detected in and around tendons (Ljung 1999, Ackermann 1999). There is 
a neurogenic hypothesis of overuse injury suggesting that nerve endings and mast cells 
mediate an adaptive response to mechanical strain (Hart 2005). Excessive load may lead to 
release of neuropeptides such as substance P and calcitonin gene-related peptide that 
stimulate the degranulation of mast cells, releasing agents that module cell activities resulting 
in pathological tendon changes. 
 
Glutamate, a potent pain mediator, and glutamate receptors have been found in tendons, 
with a higher concentration of glutamate in patients compared to controls (Alfredson 1999, 
2001). This may be an explanation to the experienced pain in Achilles tendinosis.  
But tendinopathy may also be asymptomatic and it has been suggested that pain is only the 
top of an iceberg in the pathological process of Achilles tendinopathy (Kannus 1991, Magnan 
2014).  
 
1.3.2   Diagnosis 
Mid-portion Achilles tendinopathy is diagnosed clinically as pain and swelling of the mid-
portion of the tendon and impaired performance (van Dijk 2011). Insertional Achilles 
tendinopathy is located at the insertion of the Achilles tendon into the calcaneus. (Jozsa 
1997) Some of the differential diagnoses of Achilles tendinopathy are partial tears, 
proximal pain of the myotendinous junction, paratendinopathy with inflammation or 
degeneration of the parathenon and retro- or superficial calcaneal bursitis (Jozsa 1997, 
Maffulli 1998, Krishna 2005, van Dijk 2011).  
 
1.3.3  Epidemiology 
The prevalence of overuse injuries has increased dramatically during the last decades due to 
an increased participation in sports activities (Jozsa 1997). The exact incidence and 
prevalence of Achilles tendinosis in the total population is difficult to measure. Studies of 
sports injuries are often based on reports from different kinds of caregivers with different 
population and are often non-uniform in methodology with different definition of injury and 
level of sports participation (Maffulli 2003, Sobhani 2013). In a cohort of Dutch GP 
registered patients the incidence of non-insertional Achilles tendinosis was 1.85 per 1000 
person years (de Jonge 2011). The actual incidence is probably higher since a person with a 
complaint may contact other forms of care in the first place. In a population with overuse 
injuries from running 60% were males but women under the age of 30 are at greatest risk 
(Maffulli 2003). In a population of elite gymnasts there were Achilles tendon symptoms in 
17.5% of the females and 12.5% of the males compared to none of the controls (Emerson 
2010). 
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1.3.4 Treatment 
The treatment of Achilles tendinosis is initially non-surgical. Only if other treatments have 
failed surgery is sometimes indicated (Zveiers 2014, Paavola 2002). Eccentric exercise has 
been recommended in the treatment of Achilles tendinosis since the mid-1980s and was first 
developed in 1979 (Stanish 1985, 1986). Of non-operative treatments eccentric calf muscle 
training has the best evidence and extracorporeal shockwave therapy also have some 
evidence (Mafi 2001, Rompe 2007, Rasmussen 2008, Rompe 2009, Magnussen 2009, Rowe 
2012, Roche 2013, Zweiers 2014). Other examples of treatments that have been evaluated are 
injections of various substances such as a sclerosing agent near the ventral part of the tendon 
(Alfredson 2005, van Sterkenberg 2010) or platelet-rich plasma in the degenerative area of 
the tendon (de Vos 2010, de Jonge 2011) or splinting (de Vos 2007,de Jonge 2010). A 
common problem is that in many studies Achilles tendinosis of the mid-portion is not 
differentiated from distal tendinosis even though this may affect the outcome (Jonsson 2008, 
Rasmussen 2008, Magnussen 2009, van Dijk 2011, Roche 2013). 
The mechanism behind the results of eccentric training is not fully understood. In a 
continuum model of tendinopathy three different stages are described with reactive 
tendinopathy, tendon dysrepair and degenerative tendinopathy (Cook 2009). Adding or 
removing load drives the tendon forward or back along the continuum. 
In another model four stages of tendon healing have been described, the first three stages are 
proliferative and the last stage formative (Stanish 1985). In the final stage tension is 
important for the collagen fibers to reorient. 
During the first phases of healing there is an ingrowth of nerves inside the tendons 
(Ackermann 2002). In experiments with rats increased physical activity accelerated healing 
of Achilles tendon rupture and disappearance of sensory nerves from the healing tendon 
(Bring 2007). Tendon cells have the potential to communicate through extended cell 
processes and gap junctions forming a network throughout the extracellular matrix allowing 
coordination and response to loading and damage (McNeilly 1996). 
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1.4 MAGNETIC RESONANCE IMAGING 
1.4.1 Technique 
MRI is based on the magnetic properties of the protons of the body. The use of a magnetic 
field and radio waves allows detailed imaging of the body with excellent soft tissue 
contrasts.  
When a patient is put into the MR scanner a small abundance of the protons of the body are 
lined up parallel to the main magnetic field, creating a net magnetic vector. This is called 
the longitudinal magnetization (Schild 1990). When a radio frequency pulse is sent in some 
protons pick up the energy and turn upside down and also start to spin synchronized leading 
to a decrease of the longitudinal magnetization and an increase of the transversal 
magnetization. When the radio frequency pulse is switched off the protons relax so that the 
transverse magnetization disappears and the longitudinal magnetization returns to its 
original size. The time for this relaxation is called transversal relaxation time (T2) and 
longitudinal relaxation time (T1) respectively. T2 in all tissues is influenced by 
inhomogeneity of the local magnetic field from the molecules of the tissue.  
Time to echo (TE) is the time from when the radio frequency pulse is switched off to when 
a signal, the spin echo, is collected. 
 
 
1.4.2 MRI of tendons 
The nuclear magnetic resonance properties of tissues are not only affected by the chemical 
and macromolecular structure but also by the physical organization of the macromolecules 
(Henkelman 1994). Normal Achilles tendons are slim and appear dark on conventional MR 
sequences (Quinn 1987). In the highly organized tendons the transversal signal disappears 
quickly since a large fraction of the water in tendon tissue is immobilized by tight dipolar 
coupling inside the collagen molecules. This gives a short transversal relaxation time, a short 
T2, of normal tendon tissues (Peto 1990). 
 
In MRI of Achilles tendinopathy there is thickening of the tendon and a focal or diffusely 
increased intratendinous signal (Åström 1996, Bergquist 1990, Quinn1987).  Fig 4. There are 
varying degrees of overlap of MR imaging between clinically symptomatic and non-
symptomatic tendons.  Asymptomatic Achilles tendons frequently demonstrate mild 
intratendinous signal but symptomatic tendons often have more obvious intratendinous 
signal. The subtle increase in signal found in controls may represent normal fascial 
anatomy, magic angle effects from oblique distal fibers or possibly small vessels (Soila 
1999, Haims 2000, Schweitzer 2000). 
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A                                                             B 
 
Figure 4. PD-weighted images from a 45 year old man. The symptomatic right tendon (A) 
show increased intratendinous signal and increased volume, the contralateral asymptomatic 
left tendon (B) is dark and slim. 
 
 
The increased signal seen in tendinopathy is caused by the loss of order in collagen structures 
and increase of hydrophilic ground substance which leads to a decrease of short T2 
component and an increase of long T2 component. Reduction in signal from short T2 
components may also result from a decrease into the extremely short T2 range or an 
increase in T1 (Robson 2003). All tissues contain short T2 relaxation components, but most 
tissues only have a small short T2 component. Tissues such as cortical bone, tendons, 
ligaments and menisci contain a majority of short T2 components.  
 
In the same way that the water or protons of tendons can be divided into compartments, as 
described above, the T2 of tendons can be divided into components. The shortest 
component of T2 arises from the collagen protons and from the protons of water fixed by 
two hydrogen bonds inside the collagen molecules between the alpha-chains. Their 
relaxation is dependent on the orientation of the magnetic field (Peto 1990). The second T2 
compartment is water weakly bound outside the collagen molecules. These water molecules 
are much more mobile than interstitial water but they still feel the influence of 
macromolecules. Its relaxation is determined by interference of the interstitial water on the 
collagen molecule since there is fast exchange of spin state between the immobilized water 
molecules and the less immobilized surface water (Henkelman 2001). The first of these two 
compartments is the largest with 89% of the volume (Fullerton 2007). The last T2 
component is from water in the ground substance. This component has a relaxation 
comparable to the relaxation of a protein solution. 
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The movement of protons in tendons is also dependent on the orientation of the collagen 
fibers. When the collagen fibers are oriented 55 ˚ to the magnetic field the dipolar interactions 
are minimized and T2 is increased, the so called the magic angle effect (Peto 1990, 
Henkelman 1994). The magic angle effect tends to be greater for short T2 components than 
for longer T2 components. Usually the magic angle effect is regarded as an artifact and the 
finding of increased signal intensity in tendon on sequences with low TE such as T1-, PD- 
and GRE sequences is sometimes not considered significant if the increased signal is not 
also found in a sequence with long TE (Schweitzer 2000, Fullerton 2007). But by 
deliberately placing tendons near the magic angle tissue changes that are not otherwise 
apparent may be detected (Bydder 2007). In the magic angle signal from normal tendon 
may increase as much as 600% and is usually higher than signal from pathologic tendon 
tissue in MRI sequences that are sensitive to the magic angle effect (Fullerton 2007). 
 
1.4.3 Contrast agents and dynamic enhancement 
Gadolinium is a metal with unpaired electrons causing paramagnetism (Brash 1992). 
Gadolinium based contrast agents act in low concentrations by shortening T1 of nearby 
protons and thereby increasing the signal best seen in T1-weighted images. Paradoxically in 
high concentrations the shortening of T2 dominates which gives a low signal. 
Gadopentetate dimeglumine (Magnevist®, Schering) was the first MRI contrast agent to be 
approved for clinical use in North America. Another gadolinium based contrast agent that 
has been widely used is gadodiamid (Omniscan ®, Nycomed Amersham). After intravenous 
infusion these contrast agents rapidly diffuses from the vascular compartment to equilibrate 
with the extracellular space except from in organs with special blood barriers. The 
distribution half-life of these agents is approximately 4 minutes and the elimination half-life 
is approximately 70 minutes (Abraham 2008). The plasma concentration of gadopentetate 
dimeglumine decreases with 70% within 5 minutes after intravenous injection (Brasch 
1992). During the first pass of the capillary bed 50% of gadopentetate dimeglumine diffuses 
from the blood into the extravascular compartment. Dynamic contrast-enhanced MR 
imaging may therefore give information about tissue vascularity, perfusion and capillary 
permeability by calculating the slopes from time-intensity curves (Verstrate 1994). 
Since 2000 nephrogenic systemic fibrosis (NSF) has been described as an adverse effect of 
gadolinium based contrast agents in patients with renal failure (Grobner 2006, Kuo 2007). 
NSF is a systemic disorder characterized by widespread tissue fibrosis. Gadopentetate 
dimeglumine and gadodiamid have a high risk of NSF but there are other gadolinium based 
contrast agents with low risk of NSF such as gadoterateme glumine (
 
Dotarem ®,Gothia 
medical) (Läkemedlsverket). 
1.4.4 UTE sequences 
Tendons in healthy controls have shown a mean T2 of 1.5-3.3 milliseconds (ms) at 3 Tesla 
(Juras 2013, Grosse 2015). This means that the signal has already disappeared when the echo 
signal is collected with conventional sequences such as T1 weighted sequences with TE 8–
 10 
10 ms or T2 weighted sequences with TE 50–100 ms. The lack of signal with conventional 
sequences is useful to provide a dark background against which a high signal can be 
recognized but they are not sensitive to tissue changes of different types or degrees because 
there has been little or no signal available to manipulate with (Gatehouse 2003). 
 
Sequences with ultra-short TE (UTE) use TEs as low as 0.05-0.5 ms (Gold 1995, Robson 
2003, Filho 2009). With UTE-sequences early tendon changes can be detected and quantified 
by measuring parameters such as T1, T2 and T2* (Robson 2004, Juras 2012).  
 
T2 is the transversal relaxation time when the protons are re-phased by 180 ̊ pulses during the 
T2 signal curve (Schild 1990). T2 is a fundamental property of a tissue at specific conditions 
such as field strength and temperature and is largely independent of the measurement 
technique (Robsson 2003). T2* relaxation has a more rapid signal loss than T2. With fast 
sequences such as UTE-sequences there is no time for the 180 ̊ pulses used in spin echo 
sequences and the signal disappears much faster. Instead the UTE sequence is a type of 
gradient echo (Gatehouse 2003, Robson 2003). T2* depend on both T2 relaxation and 
dephasing effects that arise from spins within a voxel and this requires knowledge of voxel 
size and field inhomogeneity within it. But when using UTE sequences the difference 
between T2 and T2* is indistinguishable (Robsson 2003). Local magnetic field 
inhomogeneity is increased with stronger external magnetic field. This affects the T2* in 
tendons with lower values at 7 Tesla compared to 3 Tesla (Juras 2012). The transversal 
relaxation in tendons decays multi-exponentially with a four-component of T2 (Peto 1990). 
But T2* is often reported as a single component value or a bi-component value with a short 
and long component (Filho 2009, Robson 2004, Juras 2012). 
 
A disadvantage of the UTE sequences is the lower signal to noise ratio caused by the shorter 
data collection time and higher bandwidths compared to conventional sequences 
(Gatehouse 2003). UTE sequences are also especially sensitive to the magic angle because of 
the short TE (Bydder 2007, Gatehouse 2003). It is therefore important that the tendon is 
placed parallel to the magnetic field when using UTE sequences.  
 
1.4.5 Effect of physical activity on tendons 
It may be important to consider the physical activity level of patients in studies with MRI of 
Achilles tendons since some studies have shown that physical activity affects the 
intrateninous signal and volume.  
 
T2* values of the Achilles tendon have been found to be significantly longer in healthy 
recreational long-distance runners than in controls especially in the mid portion where the 
mean difference was 29%. This is considered to be attributed to adaptations of the tendon 
microstructure and water content (Grosse 2015). Examination before and within 72 hours 
after 15 min of rope skipping and 6.6 km cross-country running in healthy males has shown 
an increased off-resonance saturation ratio (an indirect measurement of tissue hydration 
using UTE sequences) and decreased tendon volume indicating a loss of free water during 
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exercise (Syha 2014). In patients with Achilles tendinosis conventional MRI performed 
immediately after 30 minutes of eccentric calf-muscle training showed increased tendon 
volume and increased intratendinous signal indicating hyperemia or higher water content 
(Shalabi 2004). T2* has also been measured in tendons harvested from cadavers before and 
after 10 minutes of 1 kilogram tension. Despite that no change of single- or bi-component 
T2* could be found, a layering of exudates from the tendon during loading was visualized 
(Chang 2014). 
 
 
1.5 ASSESSMENT OF PAIN AND FUNCTION 
 
In reviews of treatment of Achilles tendinopathy most studies quantified pain by a wide 
variety of numeric pain scales. Another common outcome is return to activity (Magnussen 
2009, Malliaras 2013, Rowe 2012). We have used a modified classification described by 
Curwin and Stanish (Rolf 1997) in the first three papers of this thesis where pain is 
categorized on a six-level scale and performance on a four-level scale (Table 2 in Methods). 
This questionnaire was commonly used when the collection of data to these papers started.  
VISA-A is the first disease specific validated questionnaire (Robinson 2001). It was 
developed to measure the severity of Achilles tendinopathy containing eight questions 
covering pain, function and activity. Pain and function is reported on a visual analogue scale 
(VAS) and activity is measured using a categorical rating system. VISA-A has become a 
widely used tool for assessment of Achilles tendinopathy. In a review of conservative 
management of mid-portion Achilles tendinopathy VISA-A was used as an outcome measure 
in 29% of the reviewed papers (Rowe 2012). The VISA-A questionnaire has been adapted to 
Swedish and has been shown to be a reliable and valid instrument (Silbernagel 2005). 
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2 AIMS OF THE THESIS 
 
The general aim of this thesis was to evaluate the value of different MRI sequences and 
methods as an outcome measurement in the evaluation of treatment in chronic Achilles 
tendinosis. 
The specific aim of each study was as follows: 
Study I 
To correlate quantified intratendinous signal and tendon volume in five different MR-
sequences with the clinical parameters, in terms of pain and functional impairment, in 
patients with chronic Achilles tendinopathy. 
Study II 
To evaluate the long-term symptoms and MRI findings, four to five years after treatment 
with eccentric calf-muscle training, in patients with chronic Achilles tendinosis. 
Study III 
To evaluate the dynamic contrast-enhancement in Achilles tendinosis and to examine if an 
altered dynamic contrast-enhancement is normalized after short-term eccentric calf-muscle 
training. We also evaluated if the dynamic contrast-enhancement correlates to the subjective 
symptoms. 
Study IV 
To investigate if T2* of the Achilles tendon obtained using the UTE sequence can 
discriminate between chronic Achilles tendinosis and healthy controls, to evaluate its short-
term repeatability, estimate minimal detectable change and to evaluate if clinical symptoms 
correlate to T2*.  
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3 MATERIALS AND METHODS 
3.1 PATIENTS 
The patients of each four studies suffered from pain and local tenderness in the mid-portion 
of the Achilles tendon, 2-7 cm proximal to the calcaneal insertion. The ethics committee at 
Karolinska Institutet has approved the studies and written informed consent has been 
obtained from each study participant.  
Totally 59 patients and 10 healthy controls were examined in this thesis. In study I, II and III 
a total of 39 patients were included. They had originally been referred to the orthopedic clinic 
at our hospital. Some of these patients only appeared in one study and some of the patients 
appeared in all three studies. Table 1. In study IV 20 patients were recruited by 
advertisements and 10 healthy controls were recruited among colleagues.  
 
Study Number of patients 
I 10 
I+II 3 
I+III 3 
I+II+III 9 
II 6 
II+III 6 
III 2 
Total 39 
Table1. Overlap of patients appearing in study I, II and III. 
 
In study I all patients had unilateral symptoms and in study II, III and IV the patients had 
uni- or bilateral symptoms. In case of bilateral symptoms the most symptomatic side at 
inclusion was considered as the symptomatic tendon.  
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Study I: Twenty-five patients, 16 men and 9 women were included. Median age was 50 
years (range 37 to 71). The median duration of symptoms at inclusion was 35 months (range 
4-144 months). The level of physical activity ranged from recreational running or heavy 
labour in 10, walking or moderate work in 8 to deskwork in 7 patients.  
 
Study II: A total of 24 patients, 16 men and 8 women, were included in the study. Median 
age was 49 years (range 33–75). The median duration of symptoms at the time of inclusion 
was 12 months (range 6–120). Nine of the patients participated in sport activities on a 
regular basis at the time of the long term follow-up. Nine of the patients had or had had 
symptoms in the contralateral Achilles tendon. Two of these patients had had an operation 
on the contralateral Achilles tendon 10 and 3 years ago, respectively. 20 of the patients had 
previously participated in a heavy-loaded eccentric calf-muscle training program and had 
no other treatment during the follow-up period of 4.2 years (range 29–58) except 
acupuncture in one patient.  
 
These patients had previously been included in a study by Shalabi et al. where MRI was 
performed on 25 patients with chronic Achilles tendinopathy before and immediately after 
three months of eccentric calf-muscle training (Shalabi 2004). Of these 25 patients two 
patients had an operation in the Achilles tendon of interest since the previous study and 
were therefore excluded and three patients were not interested in participating, or could not 
be contacted.  
 
Four patients (three males and one female), with a median age of 48 years (range 36–56), 
were unable to participate in the eccentric training program for different reasons (diabetes 
mellitus, mild dementia, and, in two instances, illness in the family) and they did not get 
any other specific treatment for their Achilles tendon problems and were re-examined 
clinically and by MR after 14 months, thus forming a control group of untreated patients. 
 
Study III: 20 patients, 14 men and 6 women were included. Median age was 51 years (range 
28 to 70). Median duration of symptoms at inclusion was 31 months (range 6 to 120 months). 
In 9 of the 20 patients the Achilles tendon symptoms were sports related; at the time when 
symptoms appeared 7 patients practiced recreational running and one of them also practiced 
skiing and another also basketball. One patient practiced golf and one patient related the 
symptoms to snowboard skiing. 14 of the 20 patients had unilateral symptoms whereas 6 of 
the patients had a history of symptoms in the contralateral Achilles tendon. One of the 20 
patients had had an operation in the contralateral tendon 5 years previous to this study. None 
of the other patients had had any previous treatment other than pain medication.  
This study consists of a subgroup of a previously published patient material where MRI was 
performed before and immediately after three months of heavy loaded eccentric calf-muscle 
training (Shalabi 2004). 18 of the patients in this study also appear in study I or study II in 
this thesis. Table 1. Because of problems when performing the dynamic enhanced MRI 
(DEMRI) (three cases of incorrect contrast injection timing, one with extravasation and in 
one case intolerance of the contrast agent) only 20 patients of the original 25 patients 
participated in this study. 
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Study IV: A total of 30 subjects were included in this study, 20 patients and 10 healthy 
controls. The 20 patients, recruited by advertisements, 10 males and 10 females had a median 
age of 42.5 years (range 24 to 66 years). Median duration of symptoms was 12 months (range 
6 to 300 months). 13 of the patients had unilateral symptoms but of these patients 5 had a 
history of symptoms in the contralateral Achilles tendon. 7 of the patients had bilateral 
symptoms at the time of inclusion. 10 controls, 2 males and 8 females without history of 
Achilles tendon pain or ankle pain were recruited. The median age of the controls was 51 
years (range 26 to 57 years). 
 
 
3.2  METHODS 
 
3.2.1  Clinical outcome  
In case of bilateral Achilles tendon symptoms the patients were instructed to evaluate the 
most severe side at inclusion. At follow up they were instructed to evaluate the same tendon 
that was evaluated at inclusion. 
Study I, II and III: The clinical outcome was evaluated by a modified classification 
described by Curwin and Stanish (Rolf 1997), where pain was categorized on a six-level 
scale and performance on a four-level scale. Table 2. 
 
Study IV: The clinical outcome was measured using the VISA-A questionnaire. The results 
range from 0 to 100 where 100 represent no symptoms at all. (Robinson 2001) We used the 
VISA-A-S version, a cross-cultural adaptation of the VISA-A into Swedish (Silbernagel 
2005).  VISA-A-S is shown in page 19-20. 
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Intensity 
Level Pain Level Performance 
Mild 1 None 
1 Normal 
 2 
 
With extreme exertion only,  
 
not intense 
1 Normal 
Moderate 3 Starts with activity, lasts for 
1-2 hours after activity 
2 
 
Performance may  
 
be affected 
 4 With any athletic activity, 
 increase during activity 
3 Performance level  
significantly decreased 
Severe 5 Immediately upon any activity  
involving tendon. Sudden increase  
in pain if activity is continued,  
lasts for 12-24 hours 
3 Performance markedly  
curtailed or prevented 
 6 During daily activities 4 Unable to participate 
Table 2. Classification of level of pain and functional impairment, modified from 
Curwin&Stanish, 1984 (Rolf  1997). 
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3.2.2  Eccentric training  
In study II and III MRI and clinical scoring were performed before and after participation in 
an eccentric exercise program following a model developed by Alfredson et al. (Alfredson 
1998). Eccentric loading of the calf were done in two ways; with the knee straight and with 
the knee bent. The eccentric loading was performed with all body weight on the symptomatic 
side.Each of the two exercises was done with 15 repetitions in 3 sets (3x15 repetitions) twice 
a day for 12 weeks. The load was increased successively as tolerated by adding weights to a 
backpack. The exercise was done at home and the patients saw a physiotherapist for 
instructions shortly before the treatment started and at 12 weeks for a final follow-up. The 
patients kept a training diary and they were also contacted on telephone at 6 weeks.  
 
3.2.3  MRI acquisition 
In study I, II and III the MRI examinations were performed on a 1.5 Tesla Magnetom 
Vision (Siemens, Erlangen, Germany) In study IV a 3TeslaMagnetom Trio (Siemens 
Healthcare, Erlangen, Germany) was used. 
In all four studies both Achilles tendons were examined simultaneously using a 
commercially available CP-flexible 21×52 cm coil centred over the Achilles tendons with 
the patients in a feet-first supine position and with the feet fixed in about 15 degrees plantar 
flexion. The Achilles tendons were placed parallel to the magnetic field and in the iso-
centre of the bore. 
Study I and II: Five sagittal MR sequences were used in study I. Table 3. The same 
sagittal T1-weighted and PD-weighted images used in study I was also used in study II. All 
sagittal MR sequences were obtained with a slice thickness of 3 mm and a 0.3- mm gap. 
 
Sequence TR/TE 
(ms) 
Acquisition Time of Acquisition 
(TA)/min 
Field of view 
(FOV)/mm 
Matrix 
T1-WI 550/20 2 4.45 180 256x512 
T2-WI 35007119 1 4.48 180 410x512 
PD-WI 3500/17 1 4.48 180 410x512 
GRE-WI 460/10 2 6.19 180 410x512 
CME T1-WI 550/20 2 4.45 180 256x512 
Table 3. Parameters of the five sagittal MR sequences that were used,T1-weighted spin echo 
(T1-WI), PD/T2- weighted turbo spin-echo (T2-WI, PD-WI), Flash 2 D-weighted (GRE-WI) 
and T1-weighted spin-echo after intravenous contrast agent (CME T1-WI). 
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The contrast agent, 0.2 mmol/kg body weight of gadopentetate dimeglumine (Magnevist, 
Schering, Sweden) or gadiodamide (Omniscan, Nycomed, Amersham, Sweden), was 
injected as a bolus within 20 seconds. Immediately after the injection, the catheter was 
flushed with saline. The T1-weighted sequence after gadolinium (Gd) contrast agent 
enhancement (CME) was performed within 10 min. 
 
Study III: The sequence used for the dynamic MRI series was a sagittal Flash 2D with 3 mm 
slice thickness, TR/TE 50/9 ms, flip angle 40°, FOV 180x180 mm, matrix 128x256 mm, time 
of acquisition 31 seconds. The contrast agent (gadopentetate dimeglumine, Magnevist®, 
Schering or gadodiamid, Omniscan ®, Nycomed Amersham), 0.2 mmol/kg body weight, was 
injected by an auto-injector, 2 ml/second, via a catheter in the cubital vein followed by 20 ml 
of saline. The acquisition of the Dynamic MR series was started at the same time as the 
contrast injection. The Dynamic MR series lasted 5 minutes and 20 seconds, consisting of 5 
sets with an interval of 40-seconds followed by two sets with an interval of 80 seconds. Every 
set had four sagittal slices, two from the symptomatic tendon and two from the contralateral 
tendon.  
 
Study IV: The UTE sequence used was a 3D Flash with 0.78 mm slice thickness, TR 6 ms, a 
flip angle of 10°, field of view200x200 mm, voxel size 0.8x0.8x0.8 mm. Five different TE 
were applied: 0.07, 0.17, 0.37, 0.67 and 0.97 ms, resulting in an acquisition time of 5x3 
minutes. Before the MR examinations the patients sat down and rested for 30 minutes. Both 
Achilles tendons were examined simultaneously using a commercially available CP-flexible 
21×52 cm coil centred over the Achilles tendons. The patients were examined in a feet-first 
supine position with the feet fixed in about 15 degrees plantar flexion using a T-shaped 
vacuum cushion placed partly inside the coil. The Achilles tendons were placed parallel to the 
magnetic field and in the isocenter of the bore. Figure 5. 
The UTE-sequence was acquired twice to test repeatability after repositioning. Repositioning 
was defined as being released from the coil and standing up on the floor for a few seconds.  
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TE 0.07 ms                                            TE 0.17 ms 
 
TE 0.37 ms                                              TE 0.67 ms 
 
TE 0.97 ms 
Figure 5. UTE images obtained with the five different TE in a 66 year old man with chronic 
Achilles tendinosis in his right tendon (arrow).  
 
3.2.4 MRI evaluation 
Study I: The volume and intratendinous signal of the Achilles tendon was evaluated with a 
data program called computerized 3-D seed growing technique previously described by 
Shalabi et al (Shalabi 2005). The tendons were evaluated 2-12 cm proximal to the tendon 
insertion. Seven sagittal slices were used to cover each tendon. The pixel size was 0.35 x 0.35 
mm2 and the slice-to-slice distance 3.3 mm, giving a voxel volume of 0.35 x 0.35 x 3.3 mm3. 
The 10 cm interval volume of each tendon was masked to give a 3D-region of interest. A 
seed growing algorithm semi-automatically marked the tendon volume. The volume of the 
tendon was calculated by summing all voxels within the tendon and multiplying with the size 
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of the voxel volume. The mean signals of all tendons were also estimated from the masked 
volume. Figure 6. 
 
 
                A                                    B 
Figure 6. A computerized 3-D seed growing technique used on PD-MR images of the 
asymptomatic Achilles tendon (A) and the symptomatic right Achilles tendon (B). The 
tendon volume and the mean intratendinous signal 2-12 cm proximal to tendon insertion were 
calculated using the 3-D seed growing technique. 
 
Study II: Sagittal T1-weighted MR images were used to evaluate tendon volume and PD-
weighted MR images were used to evaluate intratendinous signal. The volume of the Achilles 
tendon was evaluated with the same method as in study I. Intratendinous signal was evaluated 
visually using a four-point semi-quantitative grading scale, a modified classification 
described by Shalabi et al( Shalabi 2005). Table 4. 
 
 
Grade 
0 No elevation of intratendinous signal 
1 Mildly elevated intratendinous signal 
2 Moderately elevated intratendinous signal 
3 Severely elevated  intratendinous signal 
Table 4. Four-point semi-quantitative grading scale for evaluation of  intratendinous signal. 
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We used T1-weighted images to measure tendon volume as tendon borders were best 
demarcated on the T1-weighted sequence. PD-weighted images were used to evaluate 
intratendinous signal since it is sensitive in revealing tendinopathy (Shalabi 2001). 
Intra- and inter-observer tests were performed to evaluate the reliability of the semi 
quantitative categorization. Two observers graded MR I (PD sequences) of 48 tendons. The 
MRI images were shown on a PACS workstation and all patient and examination data was 
hidden. The patient’s two tendons were shown in a random order for the observers. The 
replicate tests were identically performed after 7 days. 
 
Study III: The Dynamic MRI series of the symptomatic and the contralateral tendons, before 
and after three months of eccentric training, were evaluated on a Hermes workstation 
(Nuclear Diagnostics, Stockholm, Sweden). From the two sagittal slices obtained from each 
Achilles tendon in every set, the most centred one was chosen by visual estimation. A circular 
region of interest (ROI) with a radius of 2 mm was placed in the thickest part of the tendon, 
and in the horizontal direction the area with the highest signal was chosen. In the case of no 
visible signal increase the ROI was placed in the centre of the thickest part of the tendon. The 
ROI´s distance from the upper posterior margin of the calcaneal bone was noted to ensure 
correct placement of the ROI at the follow up examination. One ROI with a radius of 2 mm 
was placed in a vessel ventrally of the tendon. One ROI with a radius of 5 mm was placed in 
the fat ventrally of the tendon. Figure 7. The three ROI:s placed in the first image of the 
dynamic series were then copied and pasted into the following images of the dynamic series. 
The signal intensity (SI) of each ROI was then plotted as a function of time, reflecting the 
contrast enhancement. Since signal intensity is a relative value and changes proportionally, 
the signal intensity at each point of the dynamic series was normalized by dividing  the signal 
intensity of all subsequent intensity values with that obtained at the start of contrast injection 
(SI0) (i.e. so that SI0
AUC= (SI
 = 1). The area under the curve (AUC) was then calculated for each ROI 
from the start of contrast injection until 320 seconds later, using the trapezoid method 
(Aschton 1984).  
0+ SI1)x 40 seconds/2+( SI1+ SI2)x 40 seconds/2+ (SI2+ SI3)x 40 seconds/2+ 
(SI3+ SI4)x 40 seconds/2+ (SI4+ SI5)x 80 seconds/2+( SI5+ SI6)x 80 seconds/2- SI0
In addition to AUC, time to peak (i.e. the time from start of contrast injection until maximum 
signal), SI/s (i.e. the increase of signal intensity per second until maximum signal) and SI% 
(i.e. the increase in signal between start and peak, expressed in percent) was calculated for 
each ROI.  
 x 320 
seconds 
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Fig 7. Proton density weighted turbo spin-echo image prior to eccentric training in a 45-
year-old man with chronic Achilles tendinosis. There is a fusiform thickening of the mid-
portion of the Achilles tendon with increased intratendinous signal. The measurement 
regions of interest were placed in: A = the tendon, B = the fat ventrally of the tendon and C 
= a vessel. 
 
Study IV: T2* maps were calculated by linear least squares fitting of a mono-exponential 
model to the logarithm of the signal magnitude at all echo times. The axial slice where the 
tendon appeared the thickest in the anterior-posterior direction was selected and a ROI was 
manually delineated along the border of the tendon placed on the border of the tendon. 
Figure 8. The distance from the most distal part of the tendon insertion was noted and used at 
repeated examinations. Measurements were also made 1cm above and 1 cm below this level 
and the mean T2* was then calculated. In case of uniform tendons the estimated middle part 
of the tendon was used.  
To test reliability the image analysis was performed by two individual raters, one experienced 
musculoskeletal radiologist (rater 1) and one radiologist in training (rater 2). Each of the two 
raters performed the visual image analysis on two occasions, with a time span of minimum 2 
and maximum 4 weeks between the two analyses. Both raters were instructed in how to 
perform the analysis directly prior to the first occasion (Measurement 1), but did not get any 
instructions prior to the second occasion (Measurement 2). The two raters were blinded to 
which images belonged to the patient group and which to the control group. Both were also 
blinded to each other's results.     
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Figure 8. 1/T2* map with a ROI in the symptomatic left Achilles tendon of a 60 year old 
woman. 
3.2.5  Statistical analyses 
Statistical analyses were carried out on the SAS system for Widows in study I, II and III. In 
study IV the IBM SPSS statistics 20 was used. The 5, 1 and 0.1% levels of significance were 
considered. In the case of a statistically significant result the probability value (p-value) has 
been given. Variables of continuous and ordinal types are presented as mean and standard 
deviation or median and range (minimum-maximum). 
The statistical tests used in each study are as follows: 
Study I: The non-parametric Spearman rank correlation coefficient, r, was used in order to 
test independence between the intratendinous signal and the clinical variables, in terms of 
pain and functional impairment. The non-parametric Wilcoxon Signed Rank test was used to 
compare the differences between the symptomatic and asymptomatic contra-lateral Achilles 
tendon.  
Study II: Statistical comparisons in order to test differences between two groups were 
made by using the Mann-Whitney’s U-test or the Student’s t test for uncorrelated means, 
after validation for normal distribution by use of the Shapiro Wilk test. The within group 
analysis was made using pair wise Student’s t-test for correlated means. Multiple 
comparisons of continuous data were made by analysis of variance. The procedure 
proposed by Fisher was used to control for multiplicity. In order to evaluate hypotheses of 
variables in contingency tables, the Chi-square test was used. The inter- and intra-observer 
reliability of the semi-quantitative signal grading was analyzed with Cohen’s kappa.  
Study III: Statistical comparisons in order to test differences between independent or 
dependent groups were made by use of paired Student’s t-test for correlated variables. The 
Spearman rank order correlation was used in order to test independence between variables.  
Study IV: Statistical comparisons in order to test differences between independent or 
dependent groups were made by use of Wilcoxon rank sum test. To test short-term 
repeatability of the UTE sequence, intra-rater and inter-rater reliability the intra-class 
correlation coefficient, coefficient of variation (CV) and least significant change (LSC) were 
calculated. The LSC was calculated as 2.8 x CV% (El Maghraoui 2006).  The Spearman rank 
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order correlation was used in order to test independence between variables. When calculating 
the short-term repeatability of the UTE-sequence, differences between groups and 
independence between variablesmeasurement 1 by rater 2 was used. In case of bilateral 
symptoms the most symptomatic tendon was considered as the symptomatic tendon.  
 
4 RESULTS 
 
Study I: The severity of pain and functional impairment showed a significant correlation to 
the mean intratendinous signal in all five MR-sequences. Table 5. 
A significant difference of mean intratendinous signal between the symptomatic and the 
contralateral asymptomatic tendons was found in all sequences except in T2-weighted 
images. Table 6. 
The symptomatic Achilles tendons had a higher mean volume than the contralateral 
asymptomatic tendons, mean 8.1 (4.8-16.8) cm3 and 5.9 (4.4-7.8) cm3 
 
(P<0.001), but the 
volume of the painful Achilles tendon did not correlate with pain or functional impairment.  
Sequence Intratendinous signal Performance Pain 
 Median Range SD Spearman 
[r] 
p-value Spearman 
[r] 
p-value 
T1-WI 71 31-127 21 0.49 0.001 0.30 0.05 
T2-WI 81 59-108 10 0.29 0.05 0.36 0.01 
PD-WI 208 79-330 60 0.44 0.001 0.38 0.01 
GRE-WI 206 68-375 75 0.48 0.001 0.43 0.002 
CME T1-
WI 
104 38-195 43 0.49 0.001 0.28 0.06 
Table 5: The mean intratendinous signal of symptomatic tendons in five different sequences, 
with correlation to functional impairment and pain in 25 patients with unilateral symptoms. 
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Sequence Symptomatic 
tendon 
Asymptomatic 
tendon 
Median ∆ Median 
∆% 
 
T1-WI 71 (31-127) 68 (43-103) 5 (18-55) 7% P< 0.02 
T2-WI 81 (59-108) 80 (62-106) -1.3 (-20-17) -2% P= 0.63 
PD-WI 208 (79-330) 175 (99-255) 27 (-61-186) 18% P< 0.0001 
GRE-WI 206 (68-375) 148 (85-206) 52 (-68-227) 34% P< 0.0001 
CME T1-WI 104 (38-195) 78 (47-165) 15 (-29-125) 18% P< 0.0001 
Table 6: The median (range) intratendinous signal in the symptomatic and the contralateral 
asymptomatic tendon in five different MRI sequences. 
 
 
Study II: The semi-quantitative evaluation showed decreased intratendinous signal in the 
symptomatic treated tendons at a mean time follow-up of 4.2 years both compared to time 
of inclusion and 3 months. Table 7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       Table 7. 
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The symptomatic non-treated tendons had remaining intratendinous signal elevation 14 
months after time of inclusion. Table 8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      Table 8. 
 
 
The kappa value for the inter-observer reliability of semi-quantitative evaluation of 
intratendinous signal was 0.71 and intra-observer test–retest reliability 0.58. Kappa 
reliability values of 0.6–0.7 are considered to correspond to satisfactory agreement (Cohen 
1960). 
 
The 20 symptomatic treated tendons had a mean tendon volume of 6.7 (SD 2.0) cm³ at 
mean 4.2 years follow-up, 6.8 (SD 2.8) cm³at 3 months and 6.4 (SD 2.0) cm³ at time of 
inclusion. The change in tendon volume between inclusion and after 4.2 years was not 
significant (p=0.18).  
 
At the 4.2-year follow up, the pain had decreased in 19 of 20 of the symptomatic treated 
patients and 13 patients experienced none or only mild pain. The performance had 
improved in 17 of the 20 patients and 12 of the patients experienced normal performance. 
The decrease of pain and improvement of performance was significant both compared to 
inclusion and immediately after the eccentric calf-muscle training period (pain: p<0.001 
and <0.01) (performance: p<0.001 and <0.05).Table 9. 
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  Level of pain Level of performance 
  Median Range Median Range 
0 months 4.5 2-6 4 3-4 
3 months 3.5 1-6 3 1-4 
4.2 years 1.5 1-4 1 1-4 
Table 9.Median level of pain and functional performance in 20 patients with chronic Achilles 
tendinosis according to the classification modified from Curwin&Stanish, 1984. (Rolf 1997) 
 
 
Study III:  
Comparison between symptomatic and contralateral ankle in the 14 patients with 
unilateral symptoms: In the fat ventrally of the symptomatic tendon, AUC, SI/s and SI% 
was significantly higher than that of the asymptomatic side before, but not after, eccentric 
training. Table 10.  In the tendons there was no statistically significant difference of contrast 
enhancement between the symptomatic and the contralateral asymptomatic tendons before or 
after eccentric training.  
Comparison between before and after eccentric training in 20 patients: Mean AUC, SI/s, 
and SI% in tendon, fat and vessel did not change during eccentric training. Time to peak has 
been noted in Table 11. 
Symptoms: The median level of pain decreased from 5 to 3 after training (p < 0.01 in all 20 
patients and p < 0.05 in 14 patients with unilateral symptoms). The median level of 
performance improved from 4 to 3 after training (p < 0.01 in all 20 patients and p < 0.001 in 
14 patients with unilateral symptoms).  
Correlation of symptoms in the 20 symptomatic tendon sides: The dynamic contrast 
enhancement in tendons did not correlate to performance or pain before or after the exercise 
programme. In the fat ventrally of the tendon time to peak correlated to pain (r= 0.61, p<0.01) 
and performance (r = 0.50, p<0.05) after, but not before, training.  
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Dynamic contrast enhancement in tendon and in fat ventrally of tendon. 
 Symptomatic  
Before training 
Contralateral  
Before training 
Symptomatic  
After training 
Contralateral  
After training 
AUC tendon  80 (65) NS 66 (59) 76 (53) NS 52 (65) 
SI/s 10³ tendon 1.8 (1.5) NS 1.6 (0.8) 1.9 (1.2) NS 3.0 (4.7) 
SI% tendon 41 (21) NS 38 (18) 38 (19) NS 33 (26) 
AUC fat 31 (15) ** 20 (11) 26 (15) NS 22 (13) 
SI/s x 10³ fat  0.44 (0.24)* 0.32 (0.13) 0.43 (0.20) NS 0.34 (0.16) 
SI% fat 14.5 (7.4)** 9.5(4.9) 12.1 (6.3) NS 10.6 (5.4) 
Table 10.Mean AUC, SI/s and SI% in the symptomatic and contralateral side 
measured in the tendon and in the fat ventrally of the tendon before and after 
eccentric training, in 14 patients with unilateral symptoms. One standard 
deviation is provided within parenthesis. The significance of mean difference 
between the symptomatic and contralateral side has been noted. ***=p<0.001, 
**=p<0.01, *=p<0.05, NS= Not Significant. 
Mean time to peak contrast enhancement. 
 Symptomatic 
Before training 
Contralateral   
Before training 
Symptomatic   
After training 
Contralateral  
After training 
tendon 240 (89) 250 (78) 240 (100) NS 190 (110) * 
vessel 260 (76) 270 (61) 240 (89) NS 270 (78) NS 
 fat  300 (64) 300 (57) 290 (53) NS 300 (42) NS 
Table 11: Mean time, in seconds, to peak contrast enhancement in tendon, 
vessel and in the fat ventrally of the tendon in 20 patients. One standard 
deviation is provided within parenthesis. The p-value of the difference before 
compared to after three months of eccentric training has been noted. 
*=p<0.05, NS= Not Significant. 
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Study IV: The mean T2* relaxation times in different tendon categories are shown in  
Table 12.  
 
20 symptomatic tendons 6.99ms (SD 7.43) 
20 control tendons 1.85ms (SD 0.39) 
13 symptomatic tendons in patients with unilateral symptoms 6.69ms  (SD 5.74) 
13 asymptomatic contralateral tendons 4.04ms (SD 3.88) 
8 asymptomatic contralateral tendons with no history of tendon pain 3.08ms (SD 2.13) 
Table 12. The mean T2* relaxation time in milliseconds (ms) and its standard deviation in 
different tendon categories. 
 
There was a significant difference in mean T2* relaxation time between the 20 symptomatic 
tendons and the 20 control tendons (p<0.0001). In the 13 patients with unilateral symptoms a 
significant difference in T2* relaxation time was found between the symptomatic tendons and 
their contralateral asymptomatic tendon (p<0.01). There was no significant difference in T2* 
relaxation time between the 8 asymptomatic contralateral tendons with no history of tendon 
pain and the 20 control tendons (p=0.12). 
In the 20 patients VISA-A-S mean was 57.9 (SD 19.0). There was no significant correlation 
between VISA-A-S and T2* relaxation time in the symptomatic tendons (r = -0.30, p=0.19). 
Table 13. 
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Table 13.  Plot-diagram of VISA-A and T2* relaxation time of the symptomatic tendons in 
20 patients. 
 
 
The testing of short-term repeatability of the UTE-sequence showed a CV of 35% and LSC 
98%. Intra-class correlation of T2* relaxation time between two short-term repetitions had an 
average consistency of 0.96 (confidence interval 0.93-0.98).  
The results of the reliability test are presented in Table 14 and 15. 
 
 
 ICC CV(%) LSC(%) 
Rater 1 0.95 26 74 
Rater 2 0.99 17 48 
Table 14. Intra-rater reliability test. 
 
 
 ICC CV(%) LSC(%) 
Measurement 1 0.84 60 168 
Measurement 2 0.82 67 187 
Measurement 1+2 0.82 64 178 
Table 15. Inter-rater reliability test. 
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5 DISCUSSION 
 
5.1 GENERAL DISCUSSION INCLUDING STRENGTHS AND LIMIATIONS 
 
In study I, II and III clinical scoring of Achilles symptoms was made by a slightly modified 
questionnaire by Curwin and Stanish (Rolf 1997). This questionnaire is simple and therefore 
easy to answer but a disadvantage is that higher scores means lower performance. This is 
confusing since higher scores on performance makes association to clinical improvement. 
The modified questionnaire by Curwin and Stanish was commonly used when the collection 
of data to the first three papers started but has nowadays been  replaced by other more 
specific clinical tests. In recent years the validated and disease specific VISA-A has become 
widely used (Robinson 2001). In order to enable comparisons with other studies we chose the 
VISA-A in study IV 
 
A limitation of our and similar studies is that it may be difficult to differentiate symptoms 
from the right and left tendon when answering questionnaires. We have included patients 
both with unilateral and bilateral symptoms since it is difficult to find patients with symptoms 
only on one side. In case of bilateral symptoms the patients were supposed to answer the 
questionnaire according to the symptoms on the worst side at inclusion and on the treated side 
on follow up, but the contralateral symptoms may still influence the scores in both directions. 
This non-differential misclassification may hamper the results. Another limitation in common 
of all four studies is the heterogeneous material with both sports related and idiopathic 
tendinopathy. 
 
Study I: The computerized 3-D seed growing technique extracts the mean value of the pixels 
of the imaged tendon (Shalabi 2005). The method was developed as a quantitative assessment 
of both focal intratendinous signal-changes and more diffuse intratendinous signal-change. 
The problem with this method is its arbitrary scaling since the signal can be affected by a 
number of patient- and devise-dependent factors. One example of such a factor is differences 
in coil loading which may vary not only between scanners but also between sessions (Deoni 
2008). We know now that this kind of quantitative method is not reliable when comparing 
intratendionous signal between different occasions even when using the same MR camera, 
the same coil and the same sequences at every occasion.  
 Still, we consider the computerized 3-D seed growing technique to be reliable when 
evaluating tendon volume. Shalabi et al found the overall observer/replicate mean reliability 
of tendon volume measured in T1-WI to be 97.9% and coefficient of variation 4.9%. 
(Shalabi 2005)  
The volume was 25% higher in the symptomatic tendons compared to the contralateral non-
symptomatic tendons in our study but there was a lack of correlation to symptoms. This is 
supported by earlier studies where an increase in tendon thickness has been found in higher 
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ages (Koivunen 1995) or as a result of long lasting activity (Kvist 1991) or during and after a 
healing process (Karjalainen 1997, Möller 2001, Movin 1998).  
Even though we no longer consider the computerized 3-D seed growing technique to be 
reliable in evaluating intratendinous signal the study revealed another interesting finding. Both PD-
WI, GRE-WI, CM T1-WI and even T1-WI showed significant signal difference between 
symptomatic and contralateral asymptomatic tendons but the T2-WI did not reveal any 
significant difference. The T2 weighting is most sensitive when the TE is about the same as the 
tissue T2 (Robson 2003).  Since normal tendons have low T2 and T2 is only slightly increased 
in tendinosis this explains why T2-WI did not reveal any significant difference between 
symptomatic and contralateral asymptomatic tendons. The advantage of T2-WI rests with the 
ability of identifying rupture within the tendon or other pathological conditions such as 
peritendinous abnormality or bursitis (Åström 1996, Shweitzer 2000).  
The GRE-WI showed the highest difference of intratendinous signal between symptomatic 
and contralateral tendons and one of the strongest correlations to pain and functional 
impairment. But the GRE sequences are sensitive to the magic angle effect and may be a 
potential source of diagnostic misinterpretation. (Haims 2000, Schweitzer 2000) GRE 
sequences may reveal an intratendinous signal in 45% of the asymptomatic Achilles tendons 
(Soila 1999) and in up to 75% of the proximal patellar tendons without corresponding 
symptoms (Reiff 1995). Contrast enhanced T1-WI did not contribute to an improved 
correlation to clinical score compared to other sequences. The PD-WI was one of the most 
sensitive sequences in depicting intratendinous signal alterations and had one of the strongest 
correlations to pain and functional impairment in our study. PD weighted sequences do not 
detect a number of short T2 components but changes in proton density may be a greater source of 
contrast when imaging short T2 components than with long T2 components (Robson 2003). 
Consequently PD-WI could be recommended for asessment of the intratendinous signal. 
 
Study II: This is the only long-term follow-up with MRI of Achilles tendinosis to this date 
that we know of. There are some other studies with long-term follow-up of Achilles 
tendinosis (Öhberg 2004, Silbernagel 2011, van der Plas 2012). Two of these use ultrasound 
as an objective outcome measurement. One is a 3.8-year follow-up showing normalized 
tendon structure and decreased tendon thickness (Öhberg 2004). The normalized tendon 
structure is in parity with our findings of normalized intratendinous signal on MRI. A 5-year 
follow up of mid-portion Achilles tendinosis with Doppler ultrasound showed despite 
significantly improved VISA-A score that 47% still had some degree of neovascularization 
compared to 59% at baseline (van der Plas 2012). Both our and their study groups had 
participated in a 12 week eccentric training program. 
 
The study is limited by the fact that it lacks a randomized control group and that our four 
drop out “controls” were only followed for 14 months and not for 4.2 years. We do not 
know if our long term clinical- and MRI-findings are results of the eccentric training program 
or due to other factors.  
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The statistical results may also have been affected by the two patients that were excluded 
because of an operation in the Achilles tendon of interest since the first study and also by 
the three patients who were not interested in participating, or could not be contacted.  
The 20 patients who participated in the long-term follow-up did not undergo any other 
active treatments than the initial eccentric training program and their improvement must 
either be an effect of the performed treatment or self-healing. Arguments giving credit for 
the long-term effect of the eccentric training regimen is that the patients had had long-
standing symptoms prior to the treatment. 
 
The normal anatomy of the asymptomatic Achilles tendon is variable with distal stripes or 
punctate foci (Soila 1999). This may be a potential source of misinterpretation in semi-
quantitative evaluation of intratendinous signal. When evaluating the intra-tendinous signal 
visually focal changes are easily detected while a more diffuse intra-tendinous signal-change 
is more difficult to evaluate. 
 
The intra- and inter observer reliability of the semi-quantitative evaluation of intratendinous 
signal in this study was found to be satisfactory or near satisfactory. The inter-observer 
reliability was higher than the intra-observer test–retest reliability and this may have been 
influenced by the fact that the two observers agreed on a consensus rating shortly before the 
rating. The intra-observer re-test were performed after only 7 days, which is a bit short with 
risk of recall bias. 
 
Study III: Intratendinous signal alterations are often better revealed on CME T1-WI 
sequences, and the contrast agent increases the depicted size of the tendon lesion (Movin 
1998). An increased vascularity mainly inside but also ventrally of the symptomatic tendon 
has previously been shown (Öhberg 2001). Therefore, in theory, evaluation of dynamic 
contrast enhanced MRI should be ideal to quantify the histopathological changes that have 
been observed in chronic Achilles tendinosis.  
We found an increased contrast enhancement in the fat ventrally of the tendon in the 
symptomatic side before treatment but not after three months of treatment. The observed 
increased contrast enhancement before treatment may be due to an increased vascularity. But 
the reports of the significance of neo-vessels in Achilles tendinosis are contradictive. 
Increased vascularity has been found in symptomatic Achilles tendinosis (Öhberg 2001, 
Reiter 2004). But other studies have shown that symptoms are not invariably associated with 
vascularity (Richards 2010, van der Plas 2012, Peers 2003). Evaluation of MRI has shown 
that pre-Achilles edema was even more common in controls than in patients (Haims 2000). In 
a resent systematic review the evidence of association between improved symptoms and 
imaging parameters after eccentric exercise was low (Drew2014). This is in line with the 
lack of correlation with symptoms in our study.  
We could not show any difference of dynamic contrast enhancement in the symptomatic 
tendon compared to the contralateral tendon before or after the training programme. This 
finding is in disagreement with two previous studies that both could show an increased AUC 
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in the symptomatic tendons (Shalabi 2002, Richards 2010). This difference might be due to 
differences in duration of symptoms. The patients in Shalabi's study had median symptom 
duration of 12 months compared to 31 months in our study. In the study by Richards et al. we 
do not know the duration of symptoms. Perhaps the AUC had already returned to baseline 
due to the relatively long duration of the symptoms at the time of inclusion in our study. 
There was no significant change of contrast enhancement in tendon or fat before compared to 
after 3 months of eccentric training. Even though we could not show a change in contrast 
enhancement, perhaps our result could be due to lack of statistical power or maybe another 
method of measuring the dynamic contrast enhancement would have given other results.  
No intra- and inter-observer tests were performed to evaluate the reliability of the 
measurements. The reliability of the dynamic enhancement in vessels is probably not so 
good since the image quality did not allow differentiation of arteries from veins and the 
vessels were located in different areas in the fat ventrally of the Achilles tendons and with 
different size and orientation. 
 
Study IV: There was a significant difference of T2* relaxation between symptomatic tendons 
and control tendons and also between symptomatic tendons and contralateral asymptomatic 
tendons in patients with unilateral symptoms.  
 
The repeatability of T2* has earlier been quantified on phantoms, cadavers, trabecular bone 
and in cartilage (Brismar 2000, Fhilo 2009, Juras 2012, Qian 2013, Chang 2014) but to our 
knowledge there are no previously published results on human tendons in vivo. Only the 
repeatability of OSR (off-resonance saturation ratio), another tissue specific MR parameter, 
has been tested in human in vivo tendons as we know (Syha 2014). CV% in trabecular bone 
has been estimated to 3-6% (Brismar 2000) and in cartilage 1.3 to 20% (Qian 2013) 
depending on the area studied. In our study the obtained CV% was 35% resulting in a LSC of 
98%. These are considerably high values indicating that detection of changes might be 
difficult, especially when they are put in relation to the observed 43% difference between 
symptomatic and non-symptomatic tendon. This means that T2* measurements using UTE 
cannot be used to monitor treatment effect on the individual level and that fairly large studies 
will be needed in clinical trials. The reason for the low reproducibility at MRI is that 
relaxometric measurements are influenced from sources such as patient movements, 
temperature, hydration, position in the magnet, magic angle effect and signal to noise ratio 
(Bydder 2007, Diaz 2012, Biswas 2012). However, the excellent intra-rater (0.95 and 0.99) 
and good inter-rater (0.84 and 0.82) ICC, show a low proportion of random error in relation 
to the total variance. This means that UTE can be used to correctly classify patients with 
Achillodynia from those without. 
 
In accordance with our results a significant difference of T2* relaxation time has been 
shown by Juras et al between 10 patients with Achilles tendinosis and 10 healthy controls 
(Juras 2013). In another study Grosse et al came to similar results when evaluating the 
diagnostic value of T1 and T2* relaxation times and off resonance saturation ratios in 21 
controls and 11 patients even though they have divided their patients differently with 
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tendonopathic and non-tendinopathic tendon areas according to findings on conventional 
MRI when comparing patients to controls (Grosse 2014).  
 
To our knowledge these two studies are the only two previously published studies using UTE 
sequences comparing T2* in Achilles tendinosis and controls with correlation to clinical 
score. Juras et al found a strong correlation of T2* to Achilles tendon rupture score and 
Grosse et al found a strong correlation of T2* to VISA-A in symptomatic patients. In contrast 
we found no correlation between T2* and VISA-A in our 20 symptomatic patients. However, 
the studied patient groups are slightly different between the three studies. In the study by 
Grosse et al and in our study patients with both uni- and bilateral symptoms were included 
but while all symptomatic tendons were considered as symptomatic by Grosse et al only the 
most symptomatic tendon was considered as the symptomatic tendon in case of bilateral 
symptoms in our study. In the study by Juras et al the patients had “a symotomatic tendon”, in 
other words all patients had unilateral symptoms. Also, our patient group had symptoms only 
in the mid-portion of the Achilles tendon while the patients in the study by Grosse had 
“posterior heel pain” and the patients in the study by Juras et al had “painful Achilles 
tendon”. Since VISA-A is disease specific and we have a more homogenized patient group 
from that aspect this should in theory give better correlation in our patients. However, our 
patient group had duration of symptoms for at least 6 months while the patients of Grosse et 
al reported duration of symptoms for at least 4 weeks, indicating that their patients had more 
acute symptoms. Even though the VISA-A score of the symptomatic patients were similar 
(mean 57.9 in our study and 52.5 in their study) there is a possibility that more acute 
symptoms correlate better to T2* relaxation time than chronic symptoms. A continuum 
model of tendinpathy with three different stages of severity has been proposed (Cook 2008).  
At early tendinopathy there is inflammatory cell infiltration (Millar 2010), and this should 
perhaps be considered when comparing populations with different disease duration. It might 
be that T2* might better discriminates between a more acute phase and a later phase of 
Achillodynia than VISA-A does. The relation between changes in VISA-A and T2* 
following with recovery from Achillodynia needs further studies in order to better understand 
how to best evaluate different treatment strategies.  
 
In the eight patients with unilateral tendon pain and without history of pain in that tendon the 
T2* relaxation time seemed to be increased compared to healthy controls. Although this was 
not statistically significant the etiological causes that affect one tendon may also affect the 
contralateral tendon in the same individual even though it is painless.  
 
We have used a mono-exponential calculation of T2* relaxation time. Juras et al found a 
more significant difference of short T2* relaxation component between patients and controls 
and a stronger correlation of short T2* to Achilles tendon rupture score compared to the 
mono-exponentially calculated T2* (Juras 2013). However, the bi-exponential calculation is 
technically more difficult to implement due to the larger number of echoes required for a 
robust calculation and higher sensitivity to movements and the magic angle. The 
monoexponential calculation might therefore be better suited for analysis in a clinical setting 
(Grosse 2014).  
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5.2 CONCLUSIONS 
Study I: Increased intratendinous signal on MRI rather than the tendon volume, correlated to 
increased severity of pain and functional impairment in patients with chronic mid-portion 
Achilles tendinopathy. T2-WI correlated less to increased pain than any other sequence and 
T2-WI was unable to reveal a difference in mean intratendinous signal between the  
symptomatic and contralateral asymptomatic tendon. Contrast enhanced T1-WI did not 
contribute to an improved correlation to clinical score compared to other sequences. The PD-
WI was one of the most sensitive sequences in depicting intratendinous signal alterations; 
consequently it could be recommended for asessment of the intratendinous signal. However 
the arbitrary scaling of  intratendinous signal makes the 3-D computerized method unreliable 
as an outcome measure.  
Study II: The significantly better clinical outcome and decreased intratendinous signal on 
MRI after four to five years compared to directly after the eccentric training program 
indicates that the long-term prognosis in chronic Achilles tendinosis is good. The decrease 
in tendon volume was not statistically significant. A remaining high volume may be a 
remnant of a previous disorder.  
Study III: In the fat ventrally of the tendon there was a significantly increased contrast 
enhancement in the symptomatic side compared to the contralateral non-symptomatic side 
before treatment that disappeared after three months of training. However there was no 
significant change of enhancement before compared to after training and there was no 
correlation to symptoms. This study did not show any additional value of dynamic contrast 
enhanced MRI compared to MRI without contrast.  
Study IV:T2* relaxation time obtained with UTE sequence seems to be able to differentiate 
between chronic Achilles tendinosis and healthy controls but it was not associated with the 
clinical index. There was also a low reproducibility of the method limiting future evaluation 
of treatment effect to a group level.  
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5.3 FUTURE ASPECTS 
We are currently collecting data in a follow-up study with MR UTE sequenses and VISA-A 
at 3 and 12 months after treatment of chronic Achilles tendinosis. The patients have been 
randomized to either eccentric training or shock-wave theraphy. The aim is to investigate if 
there is a change of T2* relaxation time after treatment and if a change of T2* can be 
correlated to a change of VISA-A during follow-up.  
 
There are other techniques and modalities that remain to be more investigated; 
We have used a mono-exponential calculation of T2* relaxation time in study IV. Juras et al 
found a more significant difference of short T2* relaxation component between patients and 
controls and a stronger correlation of T2* to Achilles tendon rupture score compared the 
mono-exponential T2*. But the bi-exponential calculation is technically more difficult to 
implement (Juras 2013, Grosse 2014).  
With UTE images information about short T2 components can be calculated directly. By 
using magnetization transfer this information can be derived indirectly by saturating the 
short T2 components in the bound water compartment and determining the effect this has 
on the longer T2 components in the compartment of  less tightly bound water (Gatehouse 
2007). Magnetization transfer with off-resonance saturation  is used to quantitatively measure 
the off-resonance saturation ratio (OSR) ( Grosse 2013, Syha) OSR has been shown to have 
better sensitivity and specificity for differentiating mild and severe stages of tendinopathy 
from healthy controls compared to mean T2* (Grosse 2014). 
 
Diffusion tensor imaging and tendon fiber tracking has been  used in a retrospective study 
of patients with Achilles tendon rupture to assess the postoperative tendon microstructure. 
Diffusion tensor imaging might also be a valuable method to assess chronic tendinosis and 
response to treatment  (Sarman 2015). Dual-energy computed tomography (CT) of Achilles 
tendinosis with partial tear has also been described (Mallinson 2013). Structural detail of 
tendons is limited with conventional CT images but with dual-energy CT additional 
information is provided (Nicolaou 2012). By using two different energy levels the chemical 
composition may be calculated from the two different x-ray attenuations.
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